|
US2065593A
(en)
*
|
|
1936-12-29 |
|
Water-soluble diazoimino com |
|
FR472489A
(fr)
|
1914-02-20 |
1914-12-08 |
Stas Motor Ges M B H |
Bague de garniture métallique pour pistons
|
|
US2065900A
(en)
*
|
1935-03-23 |
1936-12-29 |
Gen Aniline Works Inc |
Dihydroxystilbene-dicarboxylic acid and a process of preparing it
|
|
US2071329A
(en)
*
|
1935-08-22 |
1937-02-23 |
Solvay Process Co |
Method of recovering phthalic anhydride
|
|
US3033578A
(en)
|
1959-08-10 |
1962-05-08 |
Gen Motors Corp |
Fluid seal
|
|
US3251837A
(en)
*
|
1962-09-14 |
1966-05-17 |
Pfizer & Co C |
Derivatives of 1, 2, 4-benzothiadiazine-1, 1-dioxides
|
|
GB1179019A
(en)
|
1967-05-23 |
1970-01-28 |
Produits Chimique Soc Et |
Polynicotinic Esters of Flavonoids
|
|
FR6928M
(https=)
*
|
1967-11-24 |
1969-05-05 |
|
|
|
US3600394A
(en)
|
1968-05-17 |
1971-08-17 |
Searle & Co |
2-aminoalkyl-3-arylisocarbostyrils
|
|
US3930024A
(en)
*
|
1969-09-02 |
1975-12-30 |
Parke Davis & Co |
Pharmaceutical compositions and methods
|
|
US3773946A
(en)
*
|
1969-09-02 |
1973-11-20 |
Parke Davis & Co |
Triglyceride-lowering compositions and methods
|
|
FR2244493A1
(en)
|
1973-08-09 |
1975-04-18 |
Pluripharm |
Flavonoid amino-acid salts - for treatment of haemorrhage, circulatory disorders and atherosclerosis
|
|
DE2349024A1
(de)
|
1973-09-26 |
1975-04-10 |
Schering Ag |
6beta,7beta-epoxy-1alpha,2alphamethylen-d-homo-4-pregnen-3,20-dione
|
|
IL64542A0
(en)
*
|
1981-12-15 |
1982-03-31 |
Yissum Res Dev Co |
Long-chain alpha,omega-dicarboxylic acids and derivatives thereof and pharmaceutical compositions containing them
|
|
JPS60136512A
(ja)
*
|
1983-12-26 |
1985-07-20 |
Eisai Co Ltd |
脂質代謝改善剤
|
|
DE3423166A1
(de)
*
|
1984-06-22 |
1986-01-02 |
Epis S.A., Zug |
Alpha-, omega-dicarbonsaeuren, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
|
|
CA1281720C
(en)
|
1984-11-08 |
1991-03-19 |
Makoto Sunagawa |
Carbapenem compounds and production thereof
|
|
DE3532279A1
(de)
*
|
1985-09-11 |
1987-03-12 |
Bayer Ag |
1,4-benzoxathiin-derivate
|
|
DE3601417A1
(de)
*
|
1986-01-20 |
1987-07-23 |
Nattermann A & Cie |
2'-alkyl-(alkenyl-) substituierte quercetine
|
|
EP0258190B1
(de)
|
1986-08-29 |
1991-11-27 |
Ciba-Geigy Ag |
Verfahren zur Herstellung von aromatischen Ether- und Thioetherverbindungen
|
|
EP0272455B1
(en)
|
1986-11-24 |
1993-02-10 |
Fujisawa Pharmaceutical Co., Ltd. |
3-Pyrrolidinylthio-1-azabicyclo [3.2.0] hept-2-ene-2-carboxylic acid compounds
|
|
GB8804058D0
(en)
|
1988-02-22 |
1988-03-23 |
Fujisawa Pharmaceutical Co |
3-alkenyl-1-azabicyclo(3 2 0)hept-2-ene-2-carboxylic acid compounds
|
|
US4925838A
(en)
|
1988-03-18 |
1990-05-15 |
Fujisawa Pharmaceutical Company, Ltd. |
3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
|
|
US4963544A
(en)
|
1988-05-23 |
1990-10-16 |
Fujisawa Pharmaceutical Company, Ltd. |
3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
|
|
GB8926981D0
(en)
|
1988-12-23 |
1990-01-17 |
Ici Plc |
Heterocyclic derivatives
|
|
WO1991000858A1
(en)
|
1989-07-07 |
1991-01-24 |
Schering Corporation |
Pharmaceutically active compounds
|
|
FR2649612A1
(fr)
*
|
1989-07-17 |
1991-01-18 |
Rhone Poulenc Sante |
Medicaments a base de derives de 1h-benzoxadiazine-4,1,2 nouveaux derives et leurs procedes de preparation
|
|
IE64358B1
(en)
|
1989-07-18 |
1995-07-26 |
Ici Plc |
Diaryl ether heterocycles
|
|
GB9018134D0
(en)
|
1989-09-29 |
1990-10-03 |
Ici Plc |
Heterocyclic derivatives
|
|
ES2098357T3
(es)
*
|
1990-06-05 |
1997-05-01 |
Toray Industries |
Derivado de indol.
|
|
JP2999579B2
(ja)
*
|
1990-07-18 |
2000-01-17 |
武田薬品工業株式会社 |
Ｄｎａおよびその用途
|
|
IE913866A1
(en)
|
1990-11-28 |
1992-06-03 |
Ici Plc |
Aryl derivatives
|
|
GB9025832D0
(en)
|
1990-11-28 |
1991-01-09 |
Ashwell Geoffrey J |
Novel films for nonlinear optical applications
|
|
US5126351A
(en)
*
|
1991-01-24 |
1992-06-30 |
Glaxo Inc. |
Antitumor compounds
|
|
MX9200299A
(es)
*
|
1991-02-07 |
1992-12-01 |
Roussel Uclaf |
Nuevos derivados biciclicos nitrogenados, su procedimiento de preparacion los nuevos compuestos intermedios obtenidos su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen.
|
|
WO1992018123A2
(en)
|
1991-04-10 |
1992-10-29 |
Octamer, Inc. |
A method for inhibition of retroviral replication
|
|
SG64322A1
(en)
|
1991-05-10 |
1999-04-27 |
Rhone Poulenc Rorer Int |
Bis mono and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
|
|
US5480883A
(en)
*
|
1991-05-10 |
1996-01-02 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
|
CN1067070A
(zh)
|
1991-05-17 |
1992-12-16 |
陆国强 |
饮料的减毒保鲜方法
|
|
US5124337A
(en)
*
|
1991-05-20 |
1992-06-23 |
Schering Corporation |
N-acyl-tetrahydroisoquinolines as inhibitors of acyl-coenzyme a:cholesterol acyl transferase
|
|
US5223506A
(en)
|
1991-06-04 |
1993-06-29 |
Glaxo Inc. |
Cyclic antitumor compounds
|
|
PT100905A
(pt)
|
1991-09-30 |
1994-02-28 |
Eisai Co Ltd |
Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
|
|
US5250679A
(en)
|
1991-10-18 |
1993-10-05 |
Genentech, Inc. |
Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor
|
|
US5474994A
(en)
*
|
1992-05-26 |
1995-12-12 |
Recordati S.A., Chemical And Pharmaceutical Company |
Bicyclic heterocyclic derivatives having α1 -adrenergic and 5HT1A
|
|
FR2689127B1
(fr)
*
|
1992-03-31 |
1994-05-06 |
Adir Cie |
Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant.
|
|
DE4215587A1
(de)
|
1992-05-12 |
1993-11-18 |
Bayer Ag |
Sulfonylbenzyl-substituierte Benzo- und Pyridopyridone
|
|
DE4215588A1
(de)
*
|
1992-05-12 |
1993-11-18 |
Bayer Ag |
Biphenylmethyl-substituierte Pyridone
|
|
GB9218334D0
(en)
|
1992-08-28 |
1992-10-14 |
Ici Plc |
Heterocyclic compounds
|
|
WO1994014763A1
(en)
|
1992-12-23 |
1994-07-07 |
Procept, Inc. |
Novel agents for inhibition of hiv infectivity and use therefor
|
|
US5464650A
(en)
|
1993-04-26 |
1995-11-07 |
Medtronic, Inc. |
Intravascular stent and method
|
|
US5824048A
(en)
|
1993-04-26 |
1998-10-20 |
Medtronic, Inc. |
Method for delivering a therapeutic substance to a body lumen
|
|
IL109705A
(en)
*
|
1993-06-17 |
1998-07-15 |
Allergan Inc |
Enzyme compositions and methods for contact lens cleaning
|
|
JPH0725761A
(ja)
*
|
1993-07-09 |
1995-01-27 |
Kureha Chem Ind Co Ltd |
軟骨保護剤
|
|
EP0709373B1
(en)
*
|
1993-07-23 |
2001-10-17 |
Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai |
Pyrrolidine derivative
|
|
US5707547A
(en)
|
1993-08-03 |
1998-01-13 |
Sumitomo Chemical Company, Limited |
Trans-olefin compounds, method for production thereof, liquid crystal composition containing the same as active ingredient, and liquid crystal element using said composition
|
|
EP0747381B1
(en)
*
|
1994-02-25 |
2001-10-31 |
Banyu Pharmaceutical Co., Ltd. |
Carbapenem derivative
|
|
FR2718329B1
(fr)
*
|
1994-03-21 |
2002-09-20 |
Rhone Poulenc Rorer Sa |
Lapin transgénique sensibilisé aux dyslipoprotéinémies.
|
|
US6048903A
(en)
*
|
1994-05-03 |
2000-04-11 |
Robert Toppo |
Treatment for blood cholesterol with trans-resveratrol
|
|
US6168776B1
(en)
*
|
1994-07-19 |
2001-01-02 |
University Of Pittsburgh |
Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
|
|
GB2292149A
(en)
|
1994-08-09 |
1996-02-14 |
Ferring Res Ltd |
Peptide inhibitors of pro-interleukin-1beta converting enzyme
|
|
PL181893B1
(pl)
|
1994-11-14 |
2001-10-31 |
Warner Lambert Co |
Zwiazki bedace pochodnymi pirymidyny i naftyrydyny oraz preparat farmaceutyczny zawierajacy je PL PL PL
|
|
IL115256A0
(en)
|
1994-11-14 |
1995-12-31 |
Warner Lambert Co |
6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use
|
|
US5446071A
(en)
|
1994-11-18 |
1995-08-29 |
Eli Lilly And Company |
Methods for lowering serum cholesterol
|
|
JP4140981B2
(ja)
*
|
1994-12-26 |
2008-08-27 |
東菱薬品工業株式会社 |
再狭窄症及び動脈硬化症治療薬
|
|
JPH08195068A
(ja)
|
1995-01-20 |
1996-07-30 |
Pioneer Electron Corp |
オーディオ信号混合装置
|
|
US5648387A
(en)
*
|
1995-03-24 |
1997-07-15 |
Warner-Lambert Company |
Carboxyalkylethers, formulations, and treatment of vascular diseases
|
|
WO1996031206A2
(en)
*
|
1995-04-07 |
1996-10-10 |
Warner-Lambert Company |
Flavones and coumarins as agents for the treatment of atherosclerosis
|
|
EP0747051B1
(en)
|
1995-06-07 |
2002-07-24 |
Eli Lilly And Company |
Treatment of diseases by inducing BEF-1 transcription factor
|
|
US5922866A
(en)
*
|
1995-08-30 |
1999-07-13 |
Otsuka Pharmaceutical Factory, Inc. |
Process for preparing quinazolin-4-one derivatives
|
|
AU4858596A
(en)
|
1995-09-15 |
1997-04-01 |
Torrey Pines Institute For Molecular Studies |
Synthesis of quinazolinone libraries
|
|
US5783577A
(en)
*
|
1995-09-15 |
1998-07-21 |
Trega Biosciences, Inc. |
Synthesis of quinazolinone libraries and derivatives thereof
|
|
RU2135494C1
(ru)
|
1995-12-01 |
1999-08-27 |
Санкио Компани Лимитед |
Гетероциклические соединения и композиция на их основе, проявляющая антагонистическое действие в отношении рецепторов тахикинина
|
|
US5756736A
(en)
*
|
1996-01-26 |
1998-05-26 |
Syntex (U.S.A.) Inc. |
Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
|
|
US5739330A
(en)
|
1996-02-05 |
1998-04-14 |
Hoechst Celanese Corporation |
Process for preparing quinazolones
|
|
US5763608A
(en)
|
1996-02-05 |
1998-06-09 |
Hoechst Celanese Corporation |
Process for preparing pyrimidine derivatives
|
|
WO1997028118A1
(en)
|
1996-02-05 |
1997-08-07 |
Hoechst Celanese Corporation |
Process for preparing anthranilic acids
|
|
CA2241551A1
(en)
|
1996-02-12 |
1997-08-14 |
Rutgers, The State University Of New Jersey |
Coralyne analogs as topoisomerase inhibitors
|
|
US6297273B1
(en)
|
1996-04-02 |
2001-10-02 |
Mars, Inc. |
Use of cocoa solids having high cocoa polyphenol content in tabletting compositions and capsule filling compositions
|
|
US5854264A
(en)
*
|
1996-07-24 |
1998-12-29 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
KR100213895B1
(ko)
*
|
1996-10-14 |
1999-08-02 |
박원훈 |
감귤류 과피 추출물, 이로부터 분리 정제된 헤스페리딘 또는 나린진을 포함하는 심혈관 질환 예방및 치료제 조성물
|
|
DE19651099A1
(de)
|
1996-12-09 |
1998-06-10 |
Consortium Elektrochem Ind |
Mehrkomponentensystem zum Verändern, Abbau oder Bleichen von Lignin, ligninhaltigen Materialien oder ähnlichen Stoffen sowie Verfahren zu seiner Anwendung
|
|
IL119971A
(en)
|
1997-01-07 |
2003-02-12 |
Yissum Res Dev Co |
Pharmaceutical compositions containing dicarboxylic acids and derivatives thereof and some novel dicarboxylic acids
|
|
AR012634A1
(es)
|
1997-05-02 |
2000-11-08 |
Sugen Inc |
Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion
|
|
US5908861A
(en)
|
1997-05-13 |
1999-06-01 |
Octamer, Inc. |
Methods for treating inflammation and inflammatory disease using pADPRT inhibitors
|
|
AU740603B2
(en)
|
1997-06-02 |
2001-11-08 |
Janssen Pharmaceutica N.V. |
(imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation
|
|
IL121165A0
(en)
|
1997-06-26 |
1997-11-20 |
Yissum Res Dev Co |
Pharmaceutical compositions containing carboxylic acids and derivatives thereof
|
|
CN1159302C
(zh)
|
1997-08-29 |
2004-07-28 |
武田舍林-普劳动物保健株式会社 |
三嗪衍生物,其制备及应用
|
|
US6635642B1
(en)
|
1997-09-03 |
2003-10-21 |
Guilford Pharmaceuticals Inc. |
PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
|
|
US6239114B1
(en)
|
1997-09-26 |
2001-05-29 |
Kgk Synergize |
Compositions and methods for treatment of neoplastic diseases with combinations of limonoids, flavonoids and tocotrienols
|
|
ATE404539T1
(de)
|
1997-10-02 |
2008-08-15 |
Eisai R&D Man Co Ltd |
Kondensierte pyridinderivate
|
|
JP2001520992A
(ja)
|
1997-10-28 |
2001-11-06 |
コリア インスティテュート オブ サイエンス アンド テクノロジー |
アシルｃｏａ−コレステロール−ｏ−アシルトランスフェラーゼ抑制剤、動脈壁上でのマクロファージ−脂質複合体蓄積の抑制剤および肝疾患予防または治療剤としてのナリンジンおよびナリンゲニン
|
|
GB9725782D0
(en)
|
1997-12-05 |
1998-02-04 |
Pfizer Ltd |
Therapeutic agents
|
|
DE19756388A1
(de)
|
1997-12-18 |
1999-06-24 |
Hoechst Marion Roussel De Gmbh |
Substituierte 2-Aryl-4-amino-chinazoline
|
|
EP1049767B1
(en)
*
|
1998-01-08 |
2005-08-17 |
Aventis Pharmaceuticals Inc. |
A transgenic rabbit that expresses a functional human lipoprotein (a)
|
|
US6414037B1
(en)
*
|
1998-01-09 |
2002-07-02 |
Pharmascience |
Pharmaceutical formulations of resveratrol and methods of use thereof
|
|
WO1999055396A1
(en)
|
1998-04-27 |
1999-11-04 |
Surmodics, Inc. |
Bioactive agent release coating
|
|
US6022901A
(en)
*
|
1998-05-13 |
2000-02-08 |
Pharmascience Inc. |
Administration of resveratrol to prevent or treat restenosis following coronary intervention
|
|
CA2345406A1
(en)
|
1998-10-19 |
2000-04-27 |
Eisai Co., Ltd. |
Analgesic
|
|
WO2000023073A1
(en)
|
1998-10-20 |
2000-04-27 |
Korea Institute Of Science And Technology |
Bioflavonoids as plasma high density lipoprotein level increasing agent
|
|
US6291456B1
(en)
|
1998-12-30 |
2001-09-18 |
Signal Pharmaceuticals, Inc. |
Compounds and methods for modulation of estrogen receptors
|
|
US6399633B1
(en)
*
|
1999-02-01 |
2002-06-04 |
Aventis Pharmaceuticals Inc. |
Use of 4-H-1-benzopryan-4-one derivatives as inhibitors of smooth muscle cell proliferation
|
|
KR20020008127A
(ko)
|
1999-03-15 |
2002-01-29 |
스티븐 에프. 웨인스톡 |
항균 활성을 갖는 6-ｏ-치환된 매크롤라이드
|
|
US6969720B2
(en)
*
|
1999-03-17 |
2005-11-29 |
Amr Technology, Inc. |
Biaryl substituted purine derivatives as potent antiproliferative agents
|
|
US6054435A
(en)
*
|
1999-03-19 |
2000-04-25 |
Abbott Laboratories |
6-O-substituted macrolides having antibacterial activity
|
|
YU72201A
(sh)
|
1999-04-28 |
2005-07-19 |
Aventis Pharma Deutschland Gmbh. |
Derivati di-aril kiseline kao ppar receptorski ligandi
|
|
CA2377232A1
(en)
|
1999-06-11 |
2000-12-21 |
Henceforth Hibernia, Inc. |
Prophylactic, therapeutic and industrial antioxidant compositions enhanced with stabilized atomic hydrogen/free electrons and methods to prepare and use such compositions
|
|
US6835755B1
(en)
*
|
1999-06-24 |
2004-12-28 |
University Of Pretoria |
Naphthoquinone derivatives and their use in the treatment and control of tuberculosis
|
|
DE19934799B4
(de)
*
|
1999-07-28 |
2008-01-24 |
Az Electronic Materials (Germany) Gmbh |
Chiral-smektische Flüssigkristallmischung und ihre Verwendung in Aktivmatrix-Displays mit hohen Kontrastwerten
|
|
US6790228B2
(en)
|
1999-12-23 |
2004-09-14 |
Advanced Cardiovascular Systems, Inc. |
Coating for implantable devices and a method of forming the same
|
|
JP5278983B2
(ja)
|
1999-11-17 |
2013-09-04 |
塩野義製薬株式会社 |
アミド化合物の新規用途
|
|
WO2001042231A2
(en)
*
|
1999-12-06 |
2001-06-14 |
Welichem Biotech Inc. |
Polyhydroxystilbenes and stilbene oxides as antisoriatic agents and protein kinase inhibitors
|
|
US6908624B2
(en)
|
1999-12-23 |
2005-06-21 |
Advanced Cardiovascular Systems, Inc. |
Coating for implantable devices and a method of forming the same
|
|
FR2804679B1
(fr)
|
2000-02-07 |
2002-04-26 |
Clariant France Sa |
Nouveaux composes phenoliques derives des dialcoxyethanals, leur procede de preparation et leur application
|
|
JP2003522810A
(ja)
|
2000-02-17 |
2003-07-29 |
アップルトン ペーパーズ インコーポレイテッド |
アルコキシ又はアリルメトキシエタンの製造方法
|
|
KR100774855B1
(ko)
|
2000-04-27 |
2007-11-08 |
아스텔라스세이야쿠 가부시키가이샤 |
축합 헤테로아릴 유도체
|
|
AU6118001A
(en)
|
2000-05-03 |
2001-11-12 |
Tularik Inc |
Combination therapeutic compositions and methods of use
|
|
JP2001335476A
(ja)
|
2000-05-29 |
2001-12-04 |
Shionogi & Co Ltd |
三環化合物の新規用途
|
|
US20020025301A1
(en)
*
|
2000-07-04 |
2002-02-28 |
Sylke Haremza |
Novel flavonoids and their use in cosmetic and dermatological preparations
|
|
US6541522B2
(en)
*
|
2000-08-16 |
2003-04-01 |
Insmed Incorporated |
Methods of using compositions containing hypotriglyceridemically active stilbenoids
|
|
CA2356544C
(en)
|
2000-10-03 |
2006-04-04 |
Warner-Lambert Company |
Pyridotriazines and pyridopyridazines
|
|
CN1478077A
(zh)
|
2000-10-05 |
2004-02-25 |
����ҩƷ��ҵ��ʽ���� |
作为apo b分泌抑制剂的苯甲酰胺化合物
|
|
CN101426763A
(zh)
*
|
2000-10-11 |
2009-05-06 |
埃斯佩里安医疗公司 |
用于胆固醇治疗和相关应用的硫化物和二硫化物化合物和组合物
|
|
JP2004531459A
(ja)
*
|
2000-10-11 |
2004-10-14 |
エスペリオン セラピューティクス，インコーポレイテッド |
コレステロールマネージメント用スルホキシドおよびビススルホキシド化合物ならびに組成物および関連する使用
|
|
IL154984A0
(en)
|
2000-10-19 |
2003-10-31 |
Merck & Co Inc |
Estrogen receptor modulators
|
|
EP1889891B1
(en)
*
|
2000-11-30 |
2017-11-22 |
Canon Kabushiki Kaisha |
Luminescence device and display apparatus
|
|
CN1486302A
(zh)
*
|
2000-12-07 |
2004-03-31 |
CV���ƹ�˾ |
作为抗冠状动脉疾病或动脉硬化的abca-1加强化合物的取代1,3,5-三嗪和嘧啶
|
|
KR100472694B1
(ko)
|
2000-12-30 |
2005-03-07 |
한국생명공학연구원 |
플라바논 유도체 및 이를 포함하는 혈중 지질 농도 관련질환의 예방 및 치료용 조성물
|
|
JP2002249483A
(ja)
|
2001-02-21 |
2002-09-06 |
Koei Chem Co Ltd |
アリール置換複素環式化合物の製造法
|
|
JP4256679B2
(ja)
*
|
2001-03-16 |
2009-04-22 |
ノボゲン リサーチ ピーティーワイ リミテッド |
再狭窄の治療方法
|
|
US20030064967A1
(en)
|
2001-04-11 |
2003-04-03 |
Jayraz Luchoomun |
Methods to increase plasma HDL cholesterol levels and improve HDL functionality with probucol monoesters
|
|
CA2447475A1
(en)
|
2001-05-25 |
2002-12-05 |
Chu-Biao Xue |
Hydantion derivatives as inhibitors of matrix metalloproteinases
|
|
WO2003007959A1
(en)
|
2001-07-16 |
2003-01-30 |
Fujisawa Pharmaceutical Co., Ltd. |
Quinoxaline derivatives which have parp inhibitory action
|
|
JP2005504047A
(ja)
|
2001-08-13 |
2005-02-10 |
チバ スペシャルティ ケミカルズ ホールディング インコーポレーテッド |
紫外線吸収剤
|
|
CA2397703C
(en)
|
2001-08-15 |
2009-04-28 |
At&T Corp. |
Systems and methods for abstracting portions of information that is represented with finite-state devices
|
|
US20040248950A1
(en)
*
|
2001-08-24 |
2004-12-09 |
Natsuki Ishizuka |
Apo ai expression accelerating agent
|
|
US8124625B2
(en)
|
2001-09-14 |
2012-02-28 |
Shionogi & Co., Ltd. |
Method of enhancing the expression of apolipoprotein AI using olefin derivatives
|
|
EP2168576A3
(en)
|
2001-09-14 |
2010-05-26 |
Shionogi & Co., Ltd. |
Tricyclic compounds for treating dyslipidemia and arteriosclerotic diseases
|
|
US7429593B2
(en)
|
2001-09-14 |
2008-09-30 |
Shionogi & Co., Ltd. |
Utilities of amide compounds
|
|
US6835469B2
(en)
*
|
2001-10-17 |
2004-12-28 |
The University Of Southern California |
Phosphorescent compounds and devices comprising the same
|
|
EP1441736A2
(en)
|
2001-10-29 |
2004-08-04 |
Novartis AG |
Use of 7h-pyrrolo[2,3-d]pyrimidine derivatives in the treatment of solid tumor diseases
|
|
US7166368B2
(en)
|
2001-11-07 |
2007-01-23 |
E. I. Du Pont De Nemours And Company |
Electroluminescent platinum compounds and devices made with such compounds
|
|
US7250512B2
(en)
|
2001-11-07 |
2007-07-31 |
E. I. Du Pont De Nemours And Company |
Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds
|
|
US6541045B1
(en)
*
|
2002-01-04 |
2003-04-01 |
Nutraceutical Corporation |
Herbal composition and method for combating inflammation
|
|
WO2003064399A1
(fr)
|
2002-01-28 |
2003-08-07 |
Ube Industries, Ltd. |
Procede de production de derive de quinazolin-4-one
|
|
US20050176796A1
(en)
|
2002-02-19 |
2005-08-11 |
D'alessio Roberto |
Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
|
|
MY140680A
(en)
|
2002-05-20 |
2010-01-15 |
Bristol Myers Squibb Co |
Hepatitis c virus inhibitors
|
|
KR20040001144A
(ko)
*
|
2002-06-27 |
2004-01-07 |
김대경 |
신규한 적혈구 세포질형 포스포리파아제 에이 투 효소,그에 대한 항체, 이들의 용도 및 제조 방법
|
|
US7067538B2
(en)
|
2002-08-09 |
2006-06-27 |
Warner-Lambert Company, Llc |
MCP-1 receptor antagonists and methods of use thereof
|
|
US20040033480A1
(en)
|
2002-08-15 |
2004-02-19 |
Wong Norman C.W. |
Use of resveratrol to regulate expression of apolipoprotein A1
|
|
US20050080024A1
(en)
|
2002-08-15 |
2005-04-14 |
Joseph Tucker |
Nitric oxide donating derivatives for the treatment of cardiovascular disorders
|
|
US20050080021A1
(en)
|
2002-08-15 |
2005-04-14 |
Joseph Tucker |
Nitric oxide donating derivatives of stilbenes, polyphenols and flavonoids for the treatment of cardiovascular disorders
|
|
EP1542948A4
(en)
|
2002-08-23 |
2008-12-17 |
Univ Connecticut |
NEW BIPHENYL AND BIPHENYLENE CANNABINOIDS
|
|
AU2003262946A1
(en)
*
|
2002-08-30 |
2004-03-19 |
Pharmacia And Upjohn Company |
Method of preventing or treating atherosclerosis or restenosis
|
|
EP1407774A1
(en)
*
|
2002-09-10 |
2004-04-14 |
LION Bioscience AG |
2-Amino-4-quinazolinones as LXR nuclear receptor binding compounds
|
|
EP1398032A1
(en)
|
2002-09-10 |
2004-03-17 |
PheneX Pharmaceuticals AG |
4-Oxo-quinazolines as LXR nuclear receptor binding compounds
|
|
AU2003284001A1
(en)
|
2002-10-07 |
2004-05-04 |
Bristol-Myers Squibb Company |
Triazolone and triazolethione derivatives
|
|
AU2003287250B9
(en)
|
2002-10-30 |
2010-01-28 |
Ptc Therapeutics, Inc. |
Identifying therapeutic compounds based on their physical-chemical properties
|
|
EP1418164A1
(en)
|
2002-11-07 |
2004-05-12 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
New stilbene derivatives and their use as aryl hydrocarbon receptor ligand antagonists
|
|
KR20050075028A
(ko)
|
2002-11-18 |
2005-07-19 |
에프. 호프만-라 로슈 아게 |
다이아지노피리미딘
|
|
JP4384053B2
(ja)
|
2002-12-13 |
2009-12-16 |
エフ．ホフマン−ラ ロシュ アーゲー |
３ｈ−キナゾリン−４−オン誘導体
|
|
JP2004203751A
(ja)
|
2002-12-24 |
2004-07-22 |
Pfizer Inc |
置換６，６−ヘテロ二環式誘導体
|
|
CA2512000C
(en)
*
|
2002-12-26 |
2011-08-09 |
Eisai Co., Ltd. |
Selective estrogen receptor modulator
|
|
AU2004230841A1
(en)
|
2003-04-03 |
2004-10-28 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of protein kinases
|
|
JP4895806B2
(ja)
|
2003-04-09 |
2012-03-14 |
エクセリクシス， インク． |
Ｔｉｅ−２モジュレータと使用方法
|
|
JP2004307440A
(ja)
|
2003-04-10 |
2004-11-04 |
Kyorin Pharmaceut Co Ltd |
２−アミノ‐１，３‐プロパンジオール誘導体とその付加塩
|
|
JP4733023B2
(ja)
|
2003-04-16 |
2011-07-27 |
ブリストル−マイヤーズ スクイブ カンパニー |
Ｃ型肝炎ウイルスの大環状イソキノリンペプチド阻害剤
|
|
SI1631295T1
(sl)
*
|
2003-06-06 |
2010-06-30 |
Arexis Ab |
Uporaba kondenziranih heterocikličnih spojin kotSCCE inhibitorjev za zdravljenje kožnih bolezni
|
|
ES2389258T3
(es)
*
|
2003-06-17 |
2012-10-24 |
Millennium Pharmaceuticals, Inc. |
Composiciones y métodos para inhibir TGF-s
|
|
WO2004113307A1
(ja)
|
2003-06-18 |
2004-12-29 |
Ube Industries, Ltd. |
ピリミジン−４−オン化合物の製造方法
|
|
US20050043300A1
(en)
*
|
2003-08-14 |
2005-02-24 |
Pfizer Inc. |
Piperazine derivatives
|
|
JP2007509035A
(ja)
*
|
2003-10-10 |
2007-04-12 |
レスバーロジックス コーポレイション |
Ｅｇｒ−１エンハンサー要素に関連する疾患の処置
|
|
RU2006112343A
(ru)
|
2003-10-28 |
2007-12-10 |
Редди Юс Терапеутикс, Инк. (Us) |
Гетероциклические соединения и способы их получения и применения
|
|
CA2549641A1
(en)
|
2003-12-19 |
2005-07-21 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
|
WO2005066162A1
(en)
|
2003-12-23 |
2005-07-21 |
Human Biomolecular Research Institute |
Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cancer
|
|
TW200536830A
(en)
|
2004-02-06 |
2005-11-16 |
Chugai Pharmaceutical Co Ltd |
1-(2H)-isoquinolone derivative
|
|
JPWO2005115993A1
(ja)
|
2004-05-31 |
2008-03-27 |
萬有製薬株式会社 |
キナゾリン誘導体
|
|
US20070218155A1
(en)
*
|
2004-08-20 |
2007-09-20 |
Kuhrts Eric H |
Methods and compositions for treating dyslipidaemia
|
|
WO2006045010A2
(en)
*
|
2004-10-20 |
2006-04-27 |
Resverlogix Corp. |
Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
|
|
KR20060079121A
(ko)
|
2004-12-31 |
2006-07-05 |
에스케이케미칼주식회사 |
당뇨 및 비만 치료예방에 유효한 퀴나졸린 유도체
|
|
CR9465A
(es)
|
2005-03-25 |
2008-06-19 |
Surface Logix Inc |
Compuestos mejorados farmacocineticamente
|
|
EP1944301A4
(en)
*
|
2005-10-27 |
2012-01-04 |
Msd Kk |
NEW BENZOXATHIIN DERIVATIVES
|
|
KR20080089416A
(ko)
|
2005-12-21 |
2008-10-06 |
페인셉터 파마 코포레이션 |
개폐 이온 통로를 조절하기 위한 조성물 및 방법
|
|
PT2118074E
(pt)
*
|
2007-02-01 |
2014-03-20 |
Resverlogix Corp |
Compostos para a prevenção e tratamento de doenças cardiovasculares
|
|
EP2005941A3
(de)
|
2007-06-01 |
2009-04-01 |
Henkel AG & Co. KGaA |
Zellverjüngende Zusammensetzungen
|
|
WO2008152471A1
(en)
|
2007-06-12 |
2008-12-18 |
Coley Pharmaceutical Group, Inc. |
Quinazoline derivative useful as toll-like receptor antagonist
|
|
SI2346837T1
(sl)
*
|
2008-06-26 |
2015-05-29 |
Resverlogix Corporation |
Postopki pripravljanja kinazolinonskih derivatov
|
|
US20110201608A1
(en)
*
|
2008-08-05 |
2011-08-18 |
Boehringer Ingelheim International Gmbh |
Substituted naphthyridines and use thereof as medicines
|
|
US8607785B2
(en)
|
2008-08-21 |
2013-12-17 |
Geno Llc |
Systems and devices for generating nitric oxide
|
|
US8952021B2
(en)
*
|
2009-01-08 |
2015-02-10 |
Resverlogix Corp. |
Compounds for the prevention and treatment of cardiovascular disease
|
|
KR101913109B1
(ko)
*
|
2009-03-18 |
2018-10-31 |
리스버로직스 코퍼레이션 |
신규한 소염제
|
|
US9757368B2
(en)
*
|
2009-04-22 |
2017-09-12 |
Resverlogix Corp. |
Anti-inflammatory agents
|